# OnCo record paper-be1040v-bevacizumab-biosimilar-clin-ther-2020 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-be1040v-bevacizumab-biosimilar-clin-ther-2020/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-be1040v-bevacizumab-biosimilar-clin-ther-2020" ;
  schema:name "Efficacy and safety of proposed bevacizumab biosimilar BE1040V in patients with metastatic colorectal cancer: a phase III, randomized, double-blind, noninferiority clinical trial"@en ;
  schema:description "A phase 3 trial at Iranian hospitals found that a locally made copy of bevacizumab controlled metastatic bowel cancer as well as the original."@en ;
  schema:url <https://onco.cc/key-papers/paper-be1040v-bevacizumab-biosimilar-clin-ther-2020/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.clinthera.2020.03.009>, <https://pubmed.ncbi.nlm.nih.gov/32334845/> ;
  schema:sameAs <https://doi.org/10.1016/j.clinthera.2020.03.009> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Rezvani H, Mortazavizadeh SM, Allahyari A, et al." ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:drugs <https://onco.cc/drugs/bevacizumab/> ;
  onco:companies <https://onco.cc/companies/aryogen-pharmed/> ;
  onco:terms <https://onco.cc/terms/biosimilar/> ;
  onco:trials <https://onco.cc/trials/nct03288987/> .